greeksoup/ stock research
Stock research / United States / SI / Insiders

Shoulder Innovations, Inc. insider trading

In twelve months insiders at Shoulder Innovations bought $215K and sold $5.5M on the open market; 6 of the 17 sales were under plans set months before.

Bought on the open market$215K7 purchases
Sold on the open market$5.5M17 sales
Sales set in advance6 of 17under Rule 10b5-1 plans
Pay taken in stock40 by own choice
New to this? How to read this page
  1. Insiders are the people who run the company: officers, directors and owners of 10% or more. They must report a trade on Form 4 within two business days.
  2. A purchase on the open market is the strongest sign: the insider spent their own money.
  3. A sale under a trading plan (Rule 10b5-1) says little: its dates were fixed months before. Sales outside a plan say more, but insiders sell for many reasons, such as taxes or a house.
  4. Grants, option exercises and shares held back for tax are left out.
  5. What is a Form 4? · Form 4 codes

What kind of trades

7 purchases worth $215K against 17 sales worth $5.5M; 6 of the sales were under plans set months before.

Purchasebought with their own money
Pay in stock, own choiceowed cash, chose shares
Sale outside a planthe insider picked the day
Sale under a plandates fixed months before
Says littlecompany plans, board pay, cash units
Bought
7 open market4 says little
Sold
11 outside a plan6 under a plan

Every Form 4 line of the last twelve months, counted by kind. The grades come from the filing itself: whether the insider paid cash, whether a plan set the date, whether pay was taken in stock by choice.

Insider trades on the share price

last twelve months

26 marks over twelve months, each in its grade: solid for the stronger signs, hollow or grey for the ones that say little.

PurchasePay in stock, own choiceSale outside a planSale under a planSays little

The blue line is the daily close over twelve months. Each mark is one insider's trades on one day, on that day's price, sized by dollar value. Solid marks are the stronger signs; hollow and grey marks say little. Hover or tap a mark for who, how much and why.

Trades worth a closer look

A purchase stands out when two or more of these hold: a senior insider, several insiders buying within 90 days, a fall of 10% or more in the three months before, or over $1 million. A sale outside a plan is judged the same way. These are the Feed's rules.

Who traded

dollars, twelve months

9 insiders traded. The most: Gilde Healthcare Holding B.V., sale outside a plan $4.4M.

One row per insider, sold to the left and bought to the right, split by grade: the paler part of a bar is the part that says little.

How it compares

every company on the site

Open-market sales, twelve months

Open-market purchases, twelve months

    The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.

    Every Form 4 line

    Purchase: bought on the open market with their own moneyTook pay in stock, own choice: owed cash, chose shares instead; a softer signSale: sold on the open market, not under a plan set in advanceSale, trading plan: under a Rule 10b5-1 plan set up months before, so the date was fixed in advanceGrey lines: plan purchases, pay in stock taken by the whole board or under a company plan, and units paid in cash; they say little about the insider's own view
    TradedInsiderRoleTypeSharesPriceValueFiling
    5 October 2026Tansey Casey MDirectorTook pay in stockone of 4 insiders the same day733$19.60$14,367Form 4
    5 October 2026Sidow Kevin K.DirectorTook pay in stockone of 4 insiders the same day892$19.60$17,483Form 4
    5 October 2026Hykes AndrewDirectorTook pay in stockone of 4 insiders the same day669$19.60$13,112Form 4
    5 October 2026Buckman PaulDirectorTook pay in stockone of 4 insiders the same day1,275$19.60$24,990Form 4
    14 September 2026Ball Robert JosephCEO & Executive ChairmanSaleafter a 1% rise over three months · 24% below its one-year high · Form 144 notice 14 September 202610,175$18.45$187,706Form 4
    26 August 2026Gilde Healthcare Holding B.V., see footnote10% ownerSaleafter a 50% rise over three months · 8% below its one-year high · Form 144 notice 29 July 20261,196$22.60$27,030Form 4
    24 August 2026Gilde Healthcare Holding B.V., see footnote10% ownerSaleafter a 52% rise over three months · 8% below its one-year high · Form 144 notice 29 July 2026681$22.62$15,404Form 4
    21 August 2026Gilde Healthcare Holding B.V., see footnote10% ownerSaleafter a 51% rise over three months · 9% below its one-year high · Form 144 notice 29 July 202620,516$22.61$463,867Form 4
    20 August 2026Gilde Healthcare Holding B.V., see footnote10% ownerSaleafter a 46% rise over three months · 9% below its one-year high · Form 144 notice 29 July 20263,900$22.60$88,140Form 4
    18 August 2026Ahearn Matthew FraserChief Operating OfficerSaletrading plan set in advance · Form 144 notice 17 August 202612,586$20.94$263,493Form 4
    18 August 2026Ahearn Matthew FraserChief Operating OfficerSaletrading plan set in advance · Form 144 notice 17 August 20261,600$21.38$34,211Form 4
    17 August 2026Ahearn Matthew FraserChief Operating OfficerSaletrading plan set in advance · Form 144 notice 17 August 20268,314$20.10$167,101Form 4
    6 August 2026Gilde Healthcare Holding B.V., see footnote10% ownerSaleafter a 76% rise over three months · 8% below its one-year high · Form 144 notice 29 July 20262,095$22.60$47,347Form 4
    5 August 2026Gilde Healthcare Holding B.V., see footnote10% ownerSaleafter a 75% rise over three months · 7% below its one-year high · Form 144 notice 29 July 20267,338$22.64$166,132Form 4
    4 August 2026Gilde Healthcare Holding B.V., see footnote10% ownerSaleafter a 76% rise over three months · 6% below its one-year high · Form 144 notice 29 July 202699,812$22.77$2.3 millionForm 4
    3 August 2026Gilde Healthcare Holding B.V., see footnote10% ownerSaleafter a 72% rise over three months · 8% below its one-year high · Form 144 notice 29 July 202610,751$22.71$244,155Form 4
    31 July 2026Gilde Healthcare Holding B.V., see Footnote10% ownerSaleafter a 68% rise over three months · 6% below its one-year high · Form 144 notice 29 July 202620,034$22.73$455,373Form 4
    30 July 2026Gilde Healthcare Holding B.V., see Footnote10% ownerSaleafter a 81% rise over three months · Form 144 notice 29 July 202628,245$23.36$659,803Form 4
    15 June 2026Ahearn Matthew FraserChief Operating OfficerSaletrading plan set in advance · Form 144 notice 12 June 20261,644$18.20$29,922Form 4
    15 June 2026Ahearn Matthew FraserChief Operating OfficerSaletrading plan set in advance · Form 144 notice 12 June 20262,500$19.26$48,148Form 4
    12 June 2026Ahearn Matthew FraserChief Operating OfficerSaletrading plan set in advance · Form 144 notice 12 June 202615,856$18.68$296,185Form 4
    13 March 2026Points Jeffrey S.Chief Financial OfficerPurchaseafter a 3% rise over three months2,000$15.00$30,000Form 4
    13 March 2026Buchholz RichardDirectorPurchaseafter a 3% rise over three months1,000$14.84$14,840Form 4
    13 March 2026Ball Robert JosephCEO & Executive ChairmanPurchaseafter a 3% rise over three months2,200$15.18$33,392Form 4
    12 December 2025Points Jeffrey S.Chief Financial OfficerPurchaseafter a 9% fall over three months1,005$14.98$15,055Form 4
    12 December 2025Ball Robert JosephCEO & Executive ChairmanPurchaseafter a 9% fall over three months3,900$14.89$58,075Form 4
    11 December 2025Points Jeffrey S.Chief Financial OfficerPurchaseafter a 0% fall over three months995$14.65$14,577Form 4
    11 December 2025Ball Robert JosephCEO & Executive ChairmanPurchaseafter a 0% fall over three months3,300$14.83$48,934Form 4
    A filing with several lines appears once per line.
    Read morePay taken in stock by the insider's own choice has the filing's footnote, word for word, in the note under it; for the others, hold the pointer on the type. An award filed at no price shows n/a.